fda remove semaglutide from shortage list As of February 21, 2025, the updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A The FDA recently removed semaglutide

Plenty of generic medication reminders exist, but Pep is purpose-built for GLP-1 users

The dual action of tirzepatide might help overcome plateaus experienced with semaglutide

Diabetics who use GLP-1s tend to secrete more insulin to lower their blood sugar, further inflaming the pancreas and resulting in pancreatitis

Mounjaro contains the active ingredient tirzepatide, whereas Ozempic is formulated using semaglutide

Emergency signs include fever with abdominal pain, persistent vomiting, and jaundice (yellowing of skin or eyes), which require urgent imaging and evaluation

Symptoms that you may experience are: Sweating Shaking Hunger Dizziness Blurred vision Confusion Fast heartbeat Some patients may need to reduce the dose of their insulin after they start Wegovy